Nikita H.
- Country
- Belgium
- Department
- Center for Evaluation of Vaccination
Research Overview
- Efficacy, Immunogenicity, and Safety of OVX836 Influenza Vaccine in Preventing RT-PCR-Confirmed Influenza Type A in Healthy Adults Aged 18-59: A Phase 2b Study
- Phase 3 Randomized Study on Efficacy and Safety of IVX-A12 Vaccine for RSV and hMPV in Adults Aged 60+
- Evaluation of Immune Response and Safety of RSVPreF3 OA and Raxtozinameran Co-administration in Adults Aged 50 and Above with Respiratory Syncytial Virus Infections
Data & Insights
Has run more than one trial at 11 of 86 partner sites.
Specializations
Respiratory Virus Prevention
This investigator specializes in studying preventive measures against respiratory syncytial virus (RSV) and human metapneumovirus (hMPV), with particular focus on vaccine development for older adults aged 60 and above.
- RSV Lower Respiratory Tract Disease
- hMPV Prevention Strategies
- Vaccine Immunogenicity Studies
The research extends to investigating vaccine co-administration with SARS-CoV-2 vaccines in adults over 50 years.
Bacterial Disease Prevention
The investigator conducts research on preventing Group B streptococcus infections and extraintestinal pathogenic Escherichia coli (ExPEC) disease through vaccination strategies.
- GBS Vaccine Development
- ExPEC Disease Prevention
- Vaccine Co-administration Studies
Research includes evaluation of combined vaccination approaches with Tdap vaccines in women of reproductive age.
Vaccine Immunology
The investigator focuses on understanding vaccine immunogenicity and immune responses in various age groups, particularly in older populations.
- Immune Response Assessment
- Vaccine Safety Profiles
- Multi-vaccine Interactions
Studies include evaluation of concurrent administration of different vaccines, including influenza vaccines in elderly populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.